Thurston Springer Miller Herd & Titak’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$93.6K Buy
2025
Q1
$64.5K Buy
2024
Q4
$67.6K Buy
2024
Q3
$61.3K Buy
2024
Q2
$64.7K Buy